Paroxysmal Sympathetic Hyperactivity: An Old but Unrecognized Condition by Monteiro, Filipa Brás et al.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000562 European Journal of Case Reports in Internal Medicine © EFIM 2017
Doi: 10.12890/2017_000562 - European Journal of Case Reports in Internal Medicine - © EFIM 2017
Paroxysmal Sympathetic Hyperactivity: 
An Old but Unrecognized Condition
Filipa Brás Monteiro, Ricardo Castro Fonseca, Rita Mendes
Internal Medicine Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
Received: 29/12/2016
Accepted: 04/01/2017
Published: 30/01/2017
How to cite this article: Monteiro F, Fonseca R, Mendes R. Paroxysmal sympathetic hyperactivity: an old but unrecognized condition. EJCRIM 2017;4: 
doi:10.12890/2017_000562
Conflicts of Interests: The Authors declare that there are no competing interests.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License
ABSTRACT
Patients who survive a traumatic brain injury (TBI) can sometimes experience symptoms of excessive sympathetic discharge. Despite being 
known about for more than 60 years, the diagnostic criteria for this condition have only recently been defined under the name "paroxysmal 
sympathetic hyperactivity". Failure to recognize this syndrome leads to excessive costs, prolonged hospital stays and delayed recovery for 
TBI patients. This case report describes a patient whose specific rehabilitation program was affected by a failure to identify this entity, even 
though he presented with many of the characteristics of this condition. 
LEARNING POINTS
• Fever is a common sign in hospitalized patients and can result in expensive investigations and prolong length of stay.
• It is crucial to consider paroxysmal sympathetic hyperactivity (PSH) as a cause of fever in traumatic brain injury patients (TBI).
• A delay in diagnosing and treating PSH can have devastating consequences for these patients' recovery programs.
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CASE PRESENTATION
The authors report the case of 27-year-old male who was aphasic and tetraplegic following a traumatic brain injury (TBI) with severe right 
hemisphere lesions sustained in a road traffic collision. Five months after the accident, the patient was readmitted to hospital because of 
nosocomial pneumonia and was started on a 10-day course of the antibiotic meropenem. No pathogens were isolated from blood or sputum 
cultures and the patient improved clinically to be stable on air, with no respiratory symptoms and negative inflammatory markers. 
Despite the apparently treated infection, the patient was still febrile with his temperature rising to 39.5°C once or twice a day with very little 
response to antipyretic drugs. During these episodes, the patient became tachycardic, hypertensive, tachypnoeic and sweated profusely. 
The patient´s mother reported that these episodes were also frequent at home and that because of them, the patient had been refused care 
in a specialized rehabilitation hospital as he was thought to be infectious. 
A complete septic screen was performed including blood, sputum (obtained from bronchoscopy), urine and liquor samples but no bacteria, 
yeast or fungus were found, and no changes were seen on imaging tests. The inflammatory markers were also negative: white cell count 
7,000×109/l (normal value <11,000×109/l), C-reactive protein <0.5 mg/dl (normal value <0.5 mg/dl) and erythrocyte sedimentation rate 23 
mm/h (normal value <20 mm/h). Both renal and liver function were normal. 
Paroxysmal sympathetic hyperactivity (PSH) was then considered as the cause of the patient’s febrile episodes. PSH is a common but 
unrecognized complication after TBI and is characterized by hypertension, tachycardia, sweating, tachypnoea and hyperthermia, the last 
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being less frequent than the other signs[1].
A consensus statement was issued only recently on the definition, nomenclature and diagnostic criteria for PSH, an entity that was previously 
poorly recognized, thus leading to delays in treatment and increased morbidity among TBI patients. In this consensus, an assessment measure 
was proposed combining a "Clinical Feature Scale" and a "Diagnosis Likelihood Tool"[2]. Our patient scored 22 points in this proposed model, 
indicating a ‘Probable’ PSH diagnosis (Table 1).
Current state-of-the art treatment for this condition with beta-blockers was initiated with propranolol 10 mg every 8 hours up-titrated 
to 30 mg every 6 hours on discharge[3]. The patient experienced complete resolution of all the described symptoms and no negative beta-
blocker side-effects were noticed. 
DISCUSSION
PSH has only been defined recently[2]. Previously, the lack of a definition and diagnostic criteria resulted in a poorly understood condition 
with a variety of symptoms that made recognition difficult. Although it has been known about for more than 60 years, it had over 31 different 
eponyms, making it very difficult to identify[2, 4].
Recognition of this syndrome is crucial for faster recovery in TBI patients, even while still in intensive care units, thus reducing complication 
rates and length of stay[5].
This is a common syndrome and failure to recognize it is associated with increased morbidity and mortality, higher health costs, longer 
hospitalizations and poorer outcomes[2]. This case report highlights the implications of missing this diagnosis as the patient had previously 
been denied admittance to a rehabilitation hospital.
Table 1. Paroxysmal sympathetic hyperactivity 
assessment measure
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